[46] Data generated from monitoring and evaluation programs will be instrumental in improving roll-out and scale-up of these biomedical prevention ... women with known HIV-infected partners ...

Explore HIV prevention options for women, including dapivirine rings and dual prevention pills, aiming to reduce infections ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

7 October 2024 (Lima, Peru) – New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention ...

Integrating biomedical HIV prevention options into already burdened health systems in resource-poor settings is likely to impact on introduction of new interventions. For example, assessment of ...

Failure to ensure that everyone has access to prevention options to protect oneself from HIV acquisition, has resulted in at ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

You've had a chance to see firsthand the development of new biomedical HIV prevention tools. What excites you the most about these innovations? What excites me most about these innovations is that ...

Africa is contributing to groundbreaking data from the PURPOSE 2 study, which explores twice-yearly lenacapavir for HIV ...